Artemether Export Market Intelligence: India's 481 Suppliers Shipping to 107 Countries — TransData Nexus 2026

Q: Who are the top artemether exporters from India?

The top artemether exporters from India are: 1. IPCA LABORATORIES LIMITED — $627.8M (69.9% market share); 2. MACLEODS PHARMACEUTICALS LTD — $48.5M (5.4% market share); 3. INNOVA CAPTAB LIMITED — $24.9M (2.8% market share); 4. MYLAN LABORATORIES LIMITED — $20.3M (2.3% market share); 5. STRIDES PHARMA SCIENCE LIMITED — $16.2M (1.8% market share). Together they account for 82.2% of India's total artemether export value.

Q: What is the total export value of artemether from India?

The total export value of artemether from India is $897.9M USD, recorded across 8,652 shipment transactions from 481 active exporters to 107 destination countries. The average shipment value is $103.8K.

Q: Which countries import artemether from India?

India exports artemether to 107 countries worldwide. The top importing countries are: KENYA (72.7% share, $652.7M), NIGERIA (5.4% share, $48.3M), TANZANIA (2.0% share, $17.7M), SUDAN (1.6% share, $14.7M), FRANCE (1.6% share, $14.2M). These five markets account for 83.3% of total export value.

Q: What is the HS code for artemether exports from India?

The primary HS code for artemether exports from India is 30046000. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of artemether exports from India?

The average unit price for artemether exports from India is $8.41 USD per unit, with prices ranging from $0.00 to $5735.20 depending on formulation, packaging, and order volume. The total market is valued at $897.9M across 8,652 shipments.

Q: Which ports handle artemether exports from India?

The primary ports for artemether exports from India are NHAVA SHEVA SEA (INNSA1) (15.3% of shipments), JNPT/ NHAVA SHEVA SEA (9.4% of shipments), JNPT (9.1% of shipments), SAHAR AIR (8.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of artemether?

India is one of the world's leading exporters of artemether due to its large base of 481 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports artemether to 107 countries, demonstrating 55% global market coverage.

Q: What certifications do Indian artemether exporters need?

Indian artemether exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import artemether from India?

There are 1,561 registered buyers importing artemether from India, spread across 107 countries. The repeat buyer rate is 65.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top artemether supplier from India?

IPCA LABORATORIES LIMITED is the leading artemether exporter from India with a market share of 69.9% and total export value of $627.8M across 600 shipments. The top 5 suppliers together control 82.2% of total export value.

Suresh Sormare

Artemether

India Pharmaceutical Trade Intelligence

$897.9M481 Suppliers107 CountriesHS 30046000

ExportsIndia → KENYA72.7%India → NIGERIA5.4%

ImportsSOUTH AFRICA → India$8.2K SWITZERLAND → India$7.2K

#1 Supplier: IPCA LABORATORIES #1 Buyer: KENYA MEDICAL

Artemether Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Artemether to the World

Between 2022 and 2026, India exported $897.9M worth of artemether across 8,652 verified shipments to 107 countries — covering 55% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is KENYA (72.7%). IPCA LABORATORIES LIMITED leads with a 69.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Artemether export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Artemether export data snapshot — $897.9M · 481 exporters · 107 countriesTransData Nexus · Indian Customs Data

Top Artemether Exporters from India

481 active exporters · Ranked by export value

View all 481 →

Top Artemether Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	IPCA LABORATORIES LIMITED	$627.8M	600	47	69.9%
2	MACLEODS PHARMACEUTICALS LTD

Top Countries Importing Artemether from India

107 destination markets · Ranked by import value

All 107 countries →

Top Countries Importing Artemether from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	KENYA	$652.7M	72.7%
2	NIGERIA	$48.3M	5.4%
3	TANZANIA	$17.7M	2.0%
4	SUDAN	$14.7M	1.6%
5	FRANCE	$14.2M	1.6%
6	CONGO	$13.9M	1.5%
7	UGANDA	$12.9M	1.4%
8	ETHIOPIA	$12.6M	1.4%
9	MOZAMBIQUE	$11.8M	1.3%
10	ANGOLA	$9.4M	1.0%

KENYA is India's largest artemether export destination, absorbing 72.7% of total exports worth $652.7M. The top 5 importing countries — KENYA, NIGERIA, TANZANIA, SUDAN, FRANCE — together account for 83.3% of India's total artemether export value. The remaining 102 destination countries collectively receive the other 16.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Artemether to India?

11 origin countries · Total import value: $24.6K

India imports artemether from 11 countries with a combined import value of $24.6K. The largest supplier is SOUTH AFRICA ($8.2K, 2 shipments), followed by SWITZERLAND and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Artemether to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SOUTH AFRICA	$8.2K	2	33.5%
2	SWITZERLAND	$7.2K	2	29.3%
3	CHINA	$3.0K	3	12.2%
4	UNITED STATES	$1.7K	2	6.8%
5	NETHERLANDS	$1.3K	1	5.5%
6	GERMANY	$1.3K	2	5.2%
7	UNITED KINGDOM	$1.0K	1	4.1%
8	BULGARIA	$645	1	2.6%
9	ZAMBIA	$175	1	0.7%
10	UGANDA	$20	32	0.1%

Showing top 10 of 11 origin countries

SOUTH AFRICA is the largest supplier of artemether to India, accounting for 33.5% of total import value. The top 5 origin countries — SOUTH AFRICA, SWITZERLAND, CHINA, UNITED STATES, NETHERLANDS — together supply 87.2% of India's artemether imports. Click any country to see detailed supplier and buyer data for that import corridor.

Artemether — Export Intelligence Video

Visual overview of India's artemether import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's artemether pharmaceutical import and export market — $897.9M in total trade, 481 verified manufacturers, and 107 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Artemether

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Artemether, an antimalarial agent, is not currently listed in the FDA's Orange Book, indicating the absence of approved Abbreviated New Drug Applications (ANDAs) for this compound in the United States. Consequently, there are no recent approvals or import alerts specific to artemether. The regulatory pathway for introducing artemether into the U.S. market would necessitate the submission of a New Drug Application (NDA) or ANDA, adhering to the FDA's stringent requirements for demonstrating safety, efficacy, and manufacturing quality.

Given that 481 Indian exporters are actively involved in the global distribution of artemether, the absence of FDA approvals suggests a potential opportunity for these manufacturers to explore the U.S. market. However, this would require substantial investment in clinical trials and regulatory compliance to meet FDA standards.

2EU & UK Regulatory Framework

In the European Union, the combination of artemether and lumefantrine has been subject to periodic safety update report single assessments (PSUSAs) by the European Medicines Agency (EMA). Notably, in October 2022, the EMA conducted a PSUSA for artemether/lumefantrine, resulting in a maintenance outcome, indicating continued monitoring without immediate regulatory changes. (ema.europa.eu)

The United Kingdom, post-Brexit, has established its own regulatory framework through the Medicines and Healthcare products Regulatory Agency (MHRA). While specific actions regarding artemether are not detailed in the provided information, the MHRA generally aligns with EMA standards, requiring comprehensive data on quality, safety, and efficacy for marketing authorization.

3WHO Essential Medicines & Global Standards

Artemether is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in treating malaria. The WHO Prequalification Programme evaluates medicines to ensure they meet global standards of quality, safety, and efficacy, facilitating their procurement by UN agencies and member states. Artemether formulations are subject to these evaluations, promoting consistent quality across international markets.

Pharmacopoeial standards for artemether are established in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). These standards provide detailed specifications for the identity, purity, and potency of artemether, ensuring uniformity in its production and quality control.

4India Regulatory Classification

In India, artemether is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of essential medicines; however, specific ceiling prices for artemether are not detailed in the provided information. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The primary patents for artemether have expired, leading to increased generic competition globally. This competitive landscape is reflected in India's export data, where 481 exporters are actively supplying artemether to 107 destination countries. The top five exporters—IPCA Laboratories Limited, Macleods Pharmaceuticals Ltd, Innova Captab Limited, Mylan Laboratories Limited, and Strides Pharma Science Limited—collectively account for a significant share of the $897.9 million USD total export value.

6Recent Industry Developments

In August 2023, the EMA adopted a positive opinion for the marketing authorization of Artesunate Amivas, an injectable formulation for severe malaria, highlighting ongoing regulatory activities in the antimalarial sector. (ema.europa.eu)

In October 2022, the EMA conducted a PSUSA for artemether/lumefantrine, resulting in a maintenance outcome, indicating continued monitoring without immediate regulatory changes. (ema.europa.eu)

In January 2020, the EMA granted orphan designation to artesunate for the treatment of malaria, reflecting ongoing efforts to address unmet medical needs in this area. (ema.europa.eu)

These developments underscore the dynamic regulatory environment surrounding antimalarial therapies, with implications for manufacturers and exporters of artemether.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Artemether

Retail & reference prices across 2 markets vs. India FOB export price of $8.41/unit

Global Price Benchmark for Artemether across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
Nigeria	$0.05	NGN	According to the National Health Insurance Scheme (NHIS) Medicine Price List, the price for a pack of 24 tablets is NGN 400.00, equating to approximately NGN 16.67 per tablet, or about $0.05 per tablet. (cdn.who.int)
WHO/UNICEF Procurement	$0.74	USD	UNICEF supplies a pack of 24 tablets for $17.73, resulting in an average price of approximately $0.74 per tablet.

India Cost Advantage

India's pharmaceutical industry holds a significant cost advantage in the production of Active Pharmaceutical Ingredients (APIs) and finished formulations. This efficiency is largely due to well-established manufacturing clusters in Hyderabad, Ahmedabad, and Mumbai, which benefit from economies of scale and a skilled workforce. Additionally, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides robust support to the industry, facilitating exports and ensuring compliance with international quality standards. *Note: Specific pricing data for the United States, United Kingdom, Germany, Australia, Brazil, Kenya, and India domestic markets were not available from the referenced government and international organization sources.*

Supply Chain Risk Assessment — Artemether

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Artemether, heavily relies on Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) imported from China. Approximately 60–70% of India's API and KSM requirements are sourced from China, creating a significant supply chain vulnerability. This dependency exposes the supply chain to risks such as geopolitical tensions, trade restrictions, and production disruptions in China.

To mitigate these risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme for bulk drugs, aiming to boost domestic manufacturing of critical KSMs, DIs, and APIs. As of September 2025, the scheme has led to the establishment of manufacturing capacity for 26 KSMs/APIs, resulting in cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore. While these initiatives are steps toward reducing dependency, the transition to self-sufficiency is ongoing, and the supply chain remains susceptible to external disruptions.

2Supplier Concentration & Single-Source Risk

The export market for Artemether from India is highly concentrated, with the top five exporters accounting for 82.2% of total exports. IPCA Laboratories Limited alone holds a dominant 69.9% share, exporting Artemether worth $627.8 million. This high concentration poses a significant single-source risk; any operational or compliance issues at IPCA could severely disrupt the global supply of Artemether.

Access Complete Artemether Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 8,652 transactions across 107 markets.

Request Demo View Pricing

Frequently Asked Questions — Artemether Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top artemether exporters from India?

The leading artemether exporters from India are IPCA LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, INNOVA CAPTAB LIMITED, and 12 others. IPCA LABORATORIES LIMITED leads with 69.9% market share ($627.8M). The top 5 suppliers together control 82.2% of total export value.

What is the total export value of artemether from India?

The total export value of artemether from India is $897.9M, recorded across 8,652 shipments from 481 active exporters to 107 countries. The average shipment value is $103.8K.

Which countries import artemether from India?

India exports artemether to 107 countries. The top importing countries are KENYA (72.7%), NIGERIA (5.4%), TANZANIA (2.0%), SUDAN (1.6%), FRANCE (1.6%), which together account for 83.3% of total export value.

What is the HS code for artemether exports from India?

The primary HS code for artemether exports from India is 30046000. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Artemether

Artemether

Top Artemether Exporters from India

Top Countries Importing Artemether from India

Who Supplies Artemether to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Artemether — Export Intelligence Video

Regulatory Landscape — Artemether

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Artemether

India Cost Advantage

Supply Chain Risk Assessment — Artemether

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Artemether Trade Intelligence

Frequently Asked Questions — Artemether Exports from India

Who are the top artemether exporters from India?

What is the total export value of artemether from India?

Which countries import artemether from India?

What is the HS code for artemether exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of artemether exports from India?

Which ports handle artemether exports from India?

Why is India a leading exporter of artemether?

What certifications do Indian artemether exporters need?

How many buyers import artemether from India?

What is the market share of the top artemether exporter from India?

Analysis Methodology